Source: Eur Respir J 2016; 47: 688-690



Rating:

Share or cite this content

Citations should be made in the following way:
Merad Mansouria, Savale Laurent, Antoun Sami, Vincent François. Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?. Eur Respir J 2016; 47: 688-690

Member's Comments

No comment yet.

Related content which might interest you: Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy Source: Eur Respir J 2016; 47: 690-691 Year: 2016 Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? Source: Eur Respir J 2015; 46: 1214-1217 Year: 2015 Evaluating the prognosis of cardiac and pulmonary patients Source: School Course 2013 - Clinical exercise testing Year: 2013 Evaluating the prognosis of cardiac and pulmonary patients Source: Course 2015 - Clinical exercise testing Year: 2015 The relationship of thrombus localization with prognosis and chronic tromboembolic pulmonary hypertension in acute pulmonary thromboembolia Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 52 (3) 1800589; 10.1183/13993003.00589-2018 Year: 2018 Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension? Source: Eur Respir J 2014; 44: 842-845 Year: 2014 The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Improved survival in medically-treated chronic thromboembolic pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer? Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Predictors of poor outcome in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues Source: Eur Respir J 2014; 44: 1121-1122 Year: 2014 Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006 Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2015; 46: 431-443 Year: 2015 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016 Year: 2017